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Abstract
Defects in actin dynamics affect activity-dependent modulation of synaptic transmission and neuronal plasticity, and
can cause cognitive impairment. A salient candidate actin-binding protein linking synaptic dysfunction to cognitive
deficits is Drebrin (DBN). However, the specific mode of how DBN is regulated at the central synapse is largely
unknown. In this study we identify and characterize the interaction of the PTEN tumor suppressor with DBN. Our
results demonstrate that PTEN binds DBN and that this interaction results in the dephosphorylation of a site present
in the DBN C-terminus - serine 647. PTEN and pS647-DBN segregate into distinct and complimentary compartments
in  neurons,  supporting  the  idea  that  PTEN  negatively  regulates  DBN  phosphorylation  at  this  site.  We  further
demonstrate that neuronal activity increases phosphorylation of DBN at S647 in hippocampal neurons in vitro and in
ex vivo hippocampus slices exhibiting seizure activity, potentially by inducing rapid dissociation of the PTEN:DBN
complex. Our results identify a novel mechanism by which PTEN is required to maintain DBN phosphorylation at
dynamic  range  and  signifies  an  unusual  regulation  of  an  actin-binding  protein  linked  to  cognitive  decline  and
degenerative conditions at the CNS synapse.
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Introduction
PTEN  (Phosphatase  and  tensin  homolog)  was  originally
identified as a tumor suppressor that negatively regulates the
Phosphatidylinositol  3-kinase  (PI3K)  signaling  pathway  [1].
Human  germline  PTEN  mutations  or  conditional  deletions  of
PTEN in mice have further been associated with neurological
disorders such as macrocephaly, seizures, mental retardation
and  autism  [2–6].  Neuronal  deficiencies  leads  to  several
abnormal  morphological  features,  including  neuron
hypertrophy, ectopic dendrites, aberrant axonal projections and
increased dendritic spine density, as well as aberrant neuronal
transmission [5,7]. Whilst most of the characterized neuronal
responses  can  be  credited  to  PTEN’s  role  in  the  regulation
PI3K signaling [8–10], PTEN has other potential mechanisms
of  action  including  functions  independent  of  the  lipid
phosphatase activity and functions in the nucleus [11,12]. The
physiological  significances  of  these  PI3K-independent  roles,
especially in neurons, remain largely unclear.
In order to understand the spatial and temporal regulation of
PTEN  function  in  the  brain,  we  searched  for  new  PTEN
protein–protein  interactions  using  mass  spectrometry.  Our
search  identified  a  new  binding  partner:  Drebrin
(developmentally regulated brain protein, DBN), a protein that
binds to actin filaments. In adult neurons, DBN accumulates in
regions  highly  enriched  in  F-actin,  such  as  neuronal  growth
cones and dendritic spines, and modulates synaptic plasticity
by affecting the spine morphology and by regulating neuronal
transmission [13,14]. Localization of DBN is important for the
function  of  DBN  in  postsynaptic  regulation,  and  there  is
PLOS ONE | www.plosone.org 1 August 2013 | Volume 8 | Issue 8 | e71957evidence that clustering of DBN in dendritic spines is regulated
by  AMPA  (2-amino-3-(3-hydroxy-5-methyl-isoxazol-4-
yl)propanoic acid) receptor activity [15]. DBN also associates
with  several  important  postsynaptic  signaling  proteins;  for
example,  it  regulates  the  synaptic  targeting  of  NMDA  (N-
Methyl-D-aspartate)  receptors  [16],  it  interacts  with  the
scaffolding protein Homer [17] and it induces the accumulation
of PSD95 (Postsynaptic density protein 95) in dendritic spines
[18]. Interestingly, reduced levels of DBN have been observed
in the hippocampus of patients with Alzheimer’s disease [19].
We  show  here  that  PTEN  interacts  directly  with  DBN  and
negatively  regulates  levels  of  S647-phosphorylation  of  DBN
independently of PI3K. Neuronal activity induces a dissociation
of  the  PTEN:DBN  complex  and  de-represses  S647-DBN
phosphorylation  leading  to  an  increase  in  S647-
phosphorylation. Our findings provide new molecular insights
into how PTEN may control synaptic functions by targeting the
actin binding protein DBN.
Results
We  performed  mass  spectrometry  analysis  of  PTEN
complexes from liver and brain and identified a brain-specific
PTEN  interaction  of  approximately  110  kD,  Drebrin  (DBN)
(Figure 1A); 5 peptides matched the DBN entry (Q07266), with
a total coverage of 15%.
The PTEN-DBN interaction requires an intact PTEN D-
loop
DBN is an actin-binding protein that accumulates in regions
enriched in F-actin, such as dendritic spines, and modulates
synaptic  plasticity  by  affecting  spine  morphology  and  by
regulating neuronal transmission [13,14]. Initial characterization
verified the PTEN-DBN interaction by co-immunoprecipitation
(co-IP)  from  rat  brain  lysate  (Figure  1B).  To  confirm  the
interaction,  FLAG-DBN  and  GFP-PTEN  were  transiently
expressed  in  HEK293  cells,  and  Flag-DBN  (or  GFP-PTEN)
protein complexes immunoprecipitated using anti-Flag-M2 (or
Figure 1.  The PTEN-DBN interaction requires an intact PTEN D-loop.  (A) Coomassie blue stained gel of immunoprecipitated
PTEN from E18 rat brain and liver. The arrow indicates the band excised from the gel for mass spectrometry analysis, which was
identified as drebrin (DBN). (B) E18 rat brain lysate was incubated with anti-PTEN antibody or control IgG; IPs were analyzed with
indicated antibodies. (C) GFP-PTEN (or control GFP) and Flag-DBN (or control Flag) were co-expressed in HEK293 cells. Following
anti-flag (left) or anti-GFP (right) IP, co-precipitates were analyzed with anti-PTEN and anti-DBN antibodies. (D) Domain structure of
PTEN and PTEN-deletion constructs. PTEN consists of an N-terminal phosphatase domain that can act on both protein and lipid
substrates. The C-terminal domain contains a C2 domain and a cluster of phosphorylation sites. In the extreme C-terminus of PTEN
a  binding  motif  for  PDZ  domains  is  present.  (E,  F)  HEK293  cells  were  co-transfected  with  indicated  constructs  before
immunoprecipitation as described in (C). Blots were analyzed with indicated antibodies. (E) In comparison to full-length PTEN, the
PTENC2 domain shows increased binding to DBN. (F) The PTEN: DBN interaction requires an intact D-loop (aa 281-312). Bar
graph represents the average band density of GFP-PTEN/ FLAG-DBN in the co-IP in three different experiments + sem. *p<0.05
relative to wt PTEN.
doi: 10.1371/journal.pone.0071957.g001
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PTEN (or anti-DBN) antibody identified the immunoprecipitated
protein complexes (Figure 1C). In order to further characterize
the  interactions  we  coexpressed  FLAG-DBN  with  different
GFP-PTEN  deletions  (Figure  1D–F).  These  experiments
identified  that  in  comparison  to  wildtype  PTEN,  a  PTEN
fragment  encompassing  only  the  structurally  defined  C2
domain (amino-acid 182-354; PTEN C2) greatly increased the
interaction  with  DBN  (Figure  1E)  and  suggested  that  the
PTEN:DBN interaction may be mediated through the PTEN C2
domain. The PTEN C2-domain incorporates a stretch of highly
conserved  amino  acids,  the  ‘deleted-loop’  (D-loop;  aa
286-309), which is susceptible to proteolysis [20] and subject to
posttranslational modification by mono- and poly-ubiquination
[21].  We  found  that  deletions  of  the  D-loop  from  full  length
PTEN (PTENΔD) and from the PTEN C2-domain (PTENC2ΔD)
decreased  the  DBN  interaction  in  comparison  to  the  parent
proteins PTEN and PTENC2, respectively (Figure 1F).
We  further  analyzed  the  interaction  by  measuring
fluorescence  resonance  energy  transfer  (FRET)  using
multiphoton  fluorescence-lifetime  imaging  microscopy  (FLIM).
Expression  of  GFP-PTEN  or  GFP-PTENΔD  alone
demonstrated normal GFP lifetime in the absence of acceptor,
whilst co-expression of GFP-PTEN with mCherry-DBN induced
a  GFP  lifetime  reduction,  indicative  of  direct  protein–protein
interaction (Figure 2A). When compared to the GFP-PTEN and
mCherry-DBN  pair,  and  in  agreement  with  our  co-IP
experiments, we found significantly reduced FRET efficiencies
when we measured lifetime reductions between GFP-PTENΔD
and DBN (Figure 2A), or between GFP-PTEN and mCherry-
DBN in the presence of cell-permeant peptide encompassing
the D-loop sequence fused to Antennapedia [22] (Figure 2B).
Similar results were obtained in neurons: When compared to
GFP-PTEN and mCherry-DBN, FRET signals were decreased
between the GFP-PTENΔD deletion mutant and mCherry-DBN.
Presence  of  the  Ant-D-loop  peptide  did  not  result  in  further
FRET reductions (Figure 2C), indicating that the peptide can be
used  specifically  to  reduce  binding  of  PTEN  to  DBN  by
competing for PTEN D-loop interactions.
We  surmised  that  the  association  of  PTEN  with  the  actin
binding  protein  DBN  may  govern  essential  processes  during
the  re-organization  of  the  actin  cytoskeleton  at  the  synapse,
potentially  involving  PI3K  dependent  signaling  mechanisms.
Both expression of DBN and overactivation of PI3K signaling
through  overexpression  of  constitutively  active  PI3K  p110
subunits induce longer dendritic spines [7,23,24] suggesting an
interaction  of  PI3K/PTEN  signaling  and  DBN  during  dendrite
filopodia  or  synapse  formation.  However,  application  of
pharmacological  inhibition  of  PI3K  by  Wortmannin  did  not
modify  the  increase  in  spine  length  induced  by  DBN
overexpression (Figure 3).
Drebrin is phosphorylated at S647
In  search  for  potential  effects  of  PTEN’s  association  with
DBN, we considered the presence of DBN amino acid residues
that could be phosphorylated in dependence of PTEN. Indeed,
DBN has been shown to be highly phosphorylated at a number
of  residues  in  different  tissues,  including  neuronal  tissue
[25–34]. We focused on a phosphorylation site embedded in a
highly  conserved  region  within  the  DBN  C-terminus  -  serine
Figure 2.  Analysis of the PTEN:DBN interaction by FRET in PC12 cells using multiphoton FLIM.  (A) Images show the
lifetime maps of FRET across cells using a pseudocolour scale (blue, normal GFP lifetime; red, FRET). GFP-PTEN (top left) and
GFP-PTENΔD (bottom left) demonstrate normal GFP lifetime in the absence of acceptor, other images show co-expression of
GFP-PTEN  (or  GFP-PTENΔD)  with  mCherry-DBN.  Bar  graph  representing  the  average  FRET  efficiency  of  16  cells  over  3
independent experiments + sem. *p<0.01. (B) Cells were incubated for 1 hour with scrambled control peptide (control) or a small
peptide derived from the PTENC2 domain (D-loop), before FRET analyses. Both peptides are fused to the antennapedia (Ant)
internalisation sequence. Bar graphs represent the average FRET efficiency of 13 cells over 3 independent experiments + sem.
*p<0.01. (C) Hippocampal neurons were transfected at 7DIV and incubated at 10DIV with Ant-control or Ant-D-loop peptides. Bar
graphs represent the average FRET efficiency of 14 cells over 3 independent experiments + sem. **p<0.005, ***p<0.001. Scale
bars: 10 µm.
doi: 10.1371/journal.pone.0071957.g002
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specific  antibody  (Figure  4A,B).  Following  affinity  purification
we  found  that  the  antibody  detects  a  band  of  approximately
110kD in brain lysates, but not in lysates in which endogenous
phosphatases  were  activated  by  incubation  at  37oC  (Figure
4C). Similarly, in cell extracts obtained from cortical neurons
expressing DBN specific siRNA, the detection of DBN as well
as  the  S647  phosphorylated  form  of  DBN,  was  greatly
decreased  (Figure  4D).  The  antibody  also  failed  to  detect
bacterially  expressed  (phosphorylation-deficient)  DBN  and  a
mutant version of YFP-DBN in which S647 was replaced with
an alanine (S647A) (Figure 4E, F). The specificity of pS647-
DBN  antibody  was  also  demonstrated  by  incubating  anti-
pS647-DBN  with  the  pS647-DBN  peptide  prior  to  staining  of
hippocampal neurons cultured in vitro (Figure 4G). Together,
these  findings  indicate  that  anti-pS647-DBN  specifically
recognizes the S647-phosphorylated form of DBN, and that this
phosphorylation  event  readily  occurs  in  brain  tissue  and  in
hippocampal neuronal cultures.
PTEN negatively regulates S647-phosphorylation of
DBN independent of PI3K
We next sought to gain insight into a potential regulation of
pS647-DBN by PTEN, and co-expressed flag-tagged DBN in
PTEN-deficient  U87MG  cells  with  PTEN  or  with  a
phosphatase-dead PTEN mutant (PTEN C124S). Analyses of
FLAG IPs indicated that pS647-DBN levels were significantly
reduced when a phosphatase active PTEN was present (Figure
4H). PTEN is thought to function primarily as an antagonist of
PI3K signaling; therefore, we tested if direct inhibition of PI3Ks
using  pharmacological  approaches  affected  levels  of  S647-
DBN phosphorylation. Interestingly, treatment of the cells with
wortmannin  did  not  alter  pS647-DBN,  indicating  that  pS647-
DBN is sensitive to a PTEN signaling pathway that operates
independently  of  PI3K  (Figure  4I).  We  then  compared  the
efficiency of PTEN in regulating pS647-DBN also with that of
PTENΔD,  which  demonstrated  reduced  interaction  with  DBN
(Figure  1).  Again,  wild  type  PTEN  significantly  reduced
phosphorylation of DBN at S647 when compared to PTENΔD
(Figure  4J).  Because  the  D-loop-deficient  PTENΔD  mutant
retains  wild-type  PTEN  catalytic  activity  [20],  this  result
indicates that an intact PTEN:DBN association was crucial for
the PTEN effect towards pS647-DBN.
S647-phosphorylation of DBN and PTEN segregate into
opposite neuronal compartments
Next, we tested for the existence of similar PTEN signaling
mechanisms  in  neurons  and  removed  PTEN  in  neurons
obtained  from  PTENflox/flox  mice  through  Cre-mediated
recombination. Infection of cortical neuronal cultures with Cre
expressing viruses caused a reduction in PTEN protein levels
to approximately 10%, resulting in a rise in Akt phosphorylation
that  coincided  with  increased  DBN  S647-phosphorylation  of
approximately 80% (Figure 5A). Direct inhibition of PI3K did not
alter pS647-DBN in neurons (Figure 5B), suggesting that the
PTEN  induced  -  PI3K  independent  -  de-phosphorylation  of
pS647-DBN  may  be  a  broad  mechanism  that  operates  in
different  cell  types.  DBN  is  highly  enriched  in  the  nervous
system and present in motile neuronal compartments such as
growth cones and dendritic spines [13,35]. We took advantage
of  the  pS647-DBN  antibody  and  analyzed  the  spatial
distributions  of  this  phosphorylation  event,  and  correlated  it
with the localization of PTEN and DBN. We were particularly
interested in the possibility of PTEN induced dephosphorylation
of  DBN  either  directly  or  as  part  of  a  protein  complex  in
dendritic  spines.  In  hippocampal  neurons  (cultured  for  1  or
15DIV)  the  staining  pattern  of  S647  phosphorylated  DBN
showed particular enrichment in growth cones and in dendritic
spines (Figure 5C–F). This was in sharp contrast to the staining
pattern of PTEN, which was present in axons and dendrites,
Figure 3.  Drebrin induced dendritic protrusions do not require PI3K.  Rat hippocampal neurons were transfected at 7 DIV with
YFP or YFP-DBN. The PI3K inhibitor wortmannin was applied at 100 nM following transfection. At 17 DIV, neurons were fixed and
the length of individual dendrite protrusions was determined from the base to the tip of the spine head using Neuron-J. To avoid
spine variability, we restricted the analysis to the primary and secondary dendrites 100-150 µm away from the soma. Each data
point represent the relative length of at least 220 protrusions measured over 3 independent experiments + sem. ***p<0.001. Scale
bar: 3 µm.
doi: 10.1371/journal.pone.0071957.g003
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Higher magnification of labeled hippocampal neurons revealed
an  enrichment  of  pS647-DBN  in  dendritic  spines,  whereas
PTEN was mainly present in the dendrite (Figure 5D, E). On
occasion, however, PTEN was found in spines (Figure 5E); this
coincided with depleted pS647-Drebrin labeling, suggesting a
degree  of  PTEN  mobility  in  entering  the  spine.  To  further
strengthen  a  mechanism  involving  negative  regulation  of
pS647-DBN  by  PTEN  in  neurons,  we  used  RFP-CRE
expressing  PTENflox/flox  neurons  and  performed
immunocytochemistry using anti-PS647-DBN. In comparison to
control RFP expression neurons, expression of Cre resulted in
an increased PS647-DBN labeling. In summary, these results
demonstrate  that  PTEN  and  pS647-DBN  segregate  into
complimentary  compartments,  strengthening  the  idea  that
PTEN can negatively regulate pS647-DBN in neurons.
Membrane depolarization induces transient
phosphorylation of DBN at S647
Spatially  restricted  control  of  protein  phosphorylation  can
trigger  changes  in  spine  morphology  and  alters  synaptic
efficacies.  We  were  interested  in  analyzing  the  molecular
mechanisms  involved  in  phosphorylating  DBN  at  S647  and
thus  blocked  sequentially  major  signaling  pathways  that  are
known to regulate structural and/or functional plasticity at the
synapse  using  pharmacological  inhibitors  [36].  None  of  the
pathways  investigated  (Rock,  PI3K,  MAPK,  CK2,  GSK-3)
influenced the level of pS647-DBN (Figure 6A). We then tested
if neuronal activity alters pS647-DBN, and used KCl treatment
or high-frequency electrical stimulation (HFS) to drive synaptic
activity in neuronal cultures. Increased network activity resulted
in  an  elevation  of  pS647-DBN  (Figure  6B),  which  occurred
within  3–10  min  (Figure  6C).  We  next  asked  whether
increasing neural network activity also induces pS647-DBN in a
Figure 4.  pS647-Drebrin is de-phosphorylated in dependence of the PTEN phosphatase activity, but independent of PI3K
signalling.  (A) Alignment of S647 DBN. DBN comprises of an N-terminal ADF/cofilin homology domain (ADF), a coiled-coil (C–C)
domain, a proline-rich stretch (P) and an unstructured C-terminus. (B) Adult rat brain homogenate was analysed by western blot
analysis and probed with anti-DBN antibody or with the affinity purified pS647-DBN antibody. (C) Brain homogenate was incubated
on ice or at 37°C for 1 hour to activate endogenous phosphatases, before western blotting and analyses. (D) Cortical neurons were
nucleofected with control or DBN specific shRNA. Neuronal lysate was analysed at 3 DIV. (E) Bacterially expressed and purified
His-DBN was probed for anti-DBN and anti-pS647-DBN antibodies. (F) Cell lysates prepared from YFP-DBN or YFP-S647A-DBN
expressing HEK293 cells were analysed by western blotting using indicated antibodies. (G) 19 DIV hippocampal neurons were
stained with pan-drebin (mouse) and pS647-DBN antibodies (rabbit) in the presence of control serum or with the pS647-DBN
peptide. Scale bar: 10 µm. (H) GFP-PTEN or the GFP-PTEN CS mutant was co-expressed with Flag-DBN in U87MG cells. Bar
graph  represents  the  average  band  density  of  pS647-DBN/DBN  in  3  independent  experiments  +  sem.  *p<0.05.  (I)  Flag-DBN
expressing U87MG cells were treated with wortmannin (wm) for 1 hour at 100 nM. (J) As in (H), but cells were co-transfected with
Flag-DBN and GFP-PTEN, or with Flag-DBN and GFP-PTENΔD. Bar graph (right) represents the average band density of pS647-
DBN/DBN in 3 independent experiments + sem. *p<0.05.
doi: 10.1371/journal.pone.0071957.g004
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cultures  exposed  to  gabazine,  which  induces  highly
synchronized  neuronal  network  activity  (seizure-like  events)
(Figure 6D), we observed a 50% increase in pS647-DBN when
compared  to  slices  with  TTX  to  abrogate  all  spontaneous
activity  (Figure  6E).  These  results  demonstrate  that  DBN  is
phosphorylated  at  S647  under  basal  conditions  in  cultured
hippocampal  neurons  as  well  as  in  organotypic  hippocampal
slice cultures, whilst increased neuronal network activity is able
to promote pS647-DBN further in both experimental paradigms.
PTEN-DBN controls steady-state levels and activity-
dependent increases in phospho-S647-DBN
We showed that pS647-DBN is negatively regulated through
physical  interactions  with  the  PTEN  phosphatase  (Figure  4),
which led us to hypothesize that PTEN might be involved in
controlling activity-dependent changes in S647 phosphorylation
Figure 5.  pS647-Drebrin is negatively regulated by PTEN in neurons independently of PI3K.  (A) Cortical neurons isolated
from PTENflox/flox mice were transduced with increasing concentrations of Cre-expressing viruses at 13 DIV. Neuronal cell lysates
were  analysed  at  19  DIV.  Bar  graph  represents  the  relative  band  density  of  pS647-DBN  and  PTEN  in  three  independent
experiments with maximal cre-virus titer used, + sem. *p<0.05, *** < 0.001. (B) Rat cortical neurons were treated with the PI3K
inhibitor LY294002 at indicated concentrations for 60 minutes before analyses of neuronal cell lysates. Bar graph represents the
average band density of pS647-DBN in three independent experiments. (C) Hippocampal neurons were cultured for 1.5 DIV and
labelled with anti-DBN, anti-pS647-DBN and anti-PTEN antibodies. (D) 18 DIV hippocampal neurons were stained with anti-DBN,
anti-pS647-DBN and anti-PTEN. Top images show a specimen images at higher magnification. DBN is highly enriched in dendritic
spines, but also found - albeit at lower levels - in the dendrite and the soma, whereas phosphorylation at S657 is more confined to
the dendritic spine compartment. (E) Hippocampal neurons were cultured for 18 DIV and stained with anti-pS647-DBN and anti-
PTEN antibodies. In dendritic spines (arrows), DBN is highly phosphorylated on pS647, whereas PTEN is mainly present in the
dendrite process. Sporadically, PTEN is found in spines (star), which coincides with depleted pS647-Drebrin labeling. (F) Cortical
neurons isolated from PTEN floxed/floxed mice were nucleofected with RFP or Cre-RFP and cultured for DIV3 before staining for
pS647-DBN. Scale bars C, D, F: 10 µm; E: 2 µm.
doi: 10.1371/journal.pone.0071957.g005
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binding of PTEN to DBN. To test this idea, we utilized FLIM
measurements in hippocampal neurons expressing GFP-PTEN
and  mCherry-DBN,  and  measured  GFP-lifetimes  following
short  KCl  exposure.  Quantification  of  these  experiments
revealed a 45% decrease in FRET efficiencies at 5 minutes of
KCl membrane depolarization, which is consistent with the idea
that  membrane  depolarization  induces  a  dissociation  of  the
PTEN:DBN complex (Figure 7A). Given that the time-course of
the  dissociation  of  PTEN:DBN  correlates  well  with  the  time-
course of the depolarization-induced increases in pS647-DBN,
we then asked if the PTEN phosphatase suppresses pS647-
DBN in non-stimulated neurons to maintain phosphorylation at
dynamic  range.  Neuronal  activity  induced  dissociation  of
Figure 6.  Phosphorylation of DBN at S647-Drebrin is increased by synaptic activity.  (A) Cortical neurons were treated with
10 µM Y27632 (Rock inhibitor), 20 µM LY294002 (PI3K inhibitor), 10 µM PD98059 (MAPK inhibitor), 10 µM DRB (CK2 inhibitor), 10
µM Lavendustin A (general kinase inhibitor) or 2 µM CT99021 (GSK-3 inhibitor) and analyzed by western blotting using indicated
antibodies.  The  anti-pMAPK  and  anti-pCRMP2  blot  verified  the  activity  of  MAPK  and  GSK-3  inhibitors,  respectively.  (B)
Hippocampal neurons were treated with KCl (20 mM) for 10 minutes, or with high frequency electrical stimulation (HFS) at 100 Hz, 1
s, twice with a 20 s interval. (C) Neurons were treated with KCl (20 mM) for indicated periods of times. Bar graph represents the
average  band  density  of  pS647-DBN/DBN  at  each  time  point  in  3  independent  experiments  +  sem  *p<0.05.  (D)  Organotypic
hippocampal slice cultures were exposed to 5 µM gabazine (n = 21) or 500 nM TTX (n = 29) and network activity was recorded for 1
hour in stratum pyramidale of the CA3 subfield. TTX-exposed cultures showed no spontaneous activity whereas gabazine exposed
cultures developed seizure-like events. A single event indicated by the asterisk is magnified. Bars demonstrate the frequency (left)
of events over a time period of 1000 s and their amplitude (right). (E) Organotypic hippocampal slice cultures were exposed to
gabazine or TTX for 1 hour lysed and analysed with the indicated antibodies. Bar graph shows the relative band density of pS647-
DBN/DBN in >7 independent samples + sem; *p<0.05.
doi: 10.1371/journal.pone.0071957.g006
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maximal DBN-phosphorylation to occur. We tested this idea in
cortical neurons isolated from PTENflox/flox mice. In comparison
to  RFP-expressing  neurons,  PTEN  removal  through  Cre-
mediated recombination increased the level of pS647-DBN, as
shown  previously  (Figure  5A).  Membrane  depolarization
induced an increase in pS647-DBN in control neurons, whilst in
neuronal  populations  with  decreased  PTEN  expression,  the
membrane  depolarization-induced  increases  in  pS647-DBN
were  not  observed  above  elevated  levels  (Figure  7B).  Thus,
loss of PTEN was associated with a higher steady-state level of
pS647-DBN  and  prevented  any  further  activity-induced
increases  in  phosphorylation.  Under  basal  control  conditions
and  during  membrane-depolarization,  the  effect  of  PTEN  on
pS647-DBN was not affected by wortmannin treatment (Figure
7B,C) highlighting the general independence of PI3K signaling
in controlling pS647-DBN.
Discussion
In this study we identify and characterize the interaction of
the PTEN tumor suppressor with DBN, an actin-binding protein
Figure  7.    Membrane  depolarisation  induced  dissocation  of  PTEN-DBN  and  increases  the  phosphorylation  of  pS647-
DBN.  (A) Neurons were transfected at 7 DIV with mCherry-DBN and GFP-PTEN and incubated until 10 DIV, before treatment with
KCl  (20  mM)  and  FLIM  measurements.  Bar  graphs  represent  the  average  FRET  efficiency  of  22  cells  over  3  independent
experiments + sem. *p<0.001. Scale bar: 10 µm (B) Cortical neurons from floxed PTEN mice expressing RFP or RFP-Cre were
cultured for 10 DIV and treated with KCl (20 mM). (C) 11 DIV rat hippocampal neurons were treated with KCl (20 mM) for 3 minutes
in the presence or absence of Wortmannin (wm) at 100 nM. Bar graph shows the relative band density of pS647-DBN in three
independent experiments +sem; *p<0.05. (D) Schematic diagram illustrating signaling relationships. DBN phosphorylation at S647 is
suppressed through physical interactions with PTEN. Synaptic activity induces a transient dissociation of the PTEN:DBN complex
and allows maximal DBN-S647 phosphorylation to occur.
doi: 10.1371/journal.pone.0071957.g007
PTEN Regulates Drebrin Phosphorylation
PLOS ONE | www.plosone.org 8 August 2013 | Volume 8 | Issue 8 | e71957highly  enriched  in  dendritic  spines.  Our  results  demonstrate
that PTEN binds DBN and that this interaction results in the
dephosphorylation of a site present in the DBN C-terminus -
serine  647.  PTEN  responds  to  synaptic  activity  through
dissociation  from  DBN,  leading  to  a  de-repression  of
phosphorylation of DBN at S647.
Immunocytochemistry  analyses  reveal  that  pS647-DBN  is
present  in  a  neuronal  compartment  exhibiting  high  actin
turnover,  which  are  largely  depleted  of  PTEN  protein.  In
conjunction with our data demonstrating that PTEN negatively
regulates  S647-DBN  phosphorylation  independent  of  PI3K
signaling, this complementary protein distribution suggests that
the  PTEN  phosphatase  may  target  pS647-DBN
dephosphorylation, either directly or as part of a higher order
protein  complex.  Direct  dephosphorylation  of  pS647-DBN  by
PTEN  is  a  feasible  molecular  mechanism,  given  that  the
tumour  suppressor  can  act  as  a  dual-specific  protein
phosphatase that is able to dephosphorylate tyrosine-, and also
-  but  less  efficiently  -  serine-  and  threonine-phosphorylated
proteins  [37].  With  regard  to  serine  and  threonine-
phosphorylated  protein  substrates,  recombinant  PTEN  was
found  to  show  a  high  degree  of  specificity  for  substrates
surrounded by extremely acidic amino acids [37], sequences
we  also  recognize  as  flanking  S647.  On  this  basis  one  can
speculate that PTEN may target pS647-DBN directly; though
further  analysis  is  required  to  understand  PTEN’s  regulatory
connection to DBN-S647 phosphorylation fully. With respect to
a putative kinase involved in phosphorylating S647-DBN site,
the  highly  negatively  charged  signature  could  point  to  a
regulation by CK2. However, inhibition of CK2 by DRB did not
alter basal levels in pS647-DBN.
Our data are consistent with the idea that PTEN functions as
a  suppressor  of  pS647-DBN  and  associated  cellular
responses.  Absence  of  PTEN  results  in  an  increased  S647-
DBN  phosphorylation,  which  approximately  reflects  levels
achieved by activity-induced mechanisms. Consequently, only
the presence of the PTEN phosphatase suppressor allows the
system to respond with changes in pS647-DBN. Rather than
an activity-dependent regulation of a kinase being required for
the induction of pS647-DBN, it seems that dissociation of the
PTEN-DBN complex may set the degree to which pS647-DBN
is  changing  following  membrane  depolarization  (Figure  7D).
The  fact  that  a  portion  of  DBN  is  readily  phosphorylated  at
S647 under basal conditions suggests that the kinase involved
may  be  dominant  over  PTEN  mediated  de-phosphorylation.
Alternatively,  the  decreased  abundance  of  PTEN  protein
residing  deep  in  the  dendritic  spine  compartment  may  allow
spine associated DBN to maintain high basal levels of pS647-
DBN. In fact, the results of our immunofluorescence labeling
support the idea that PTEN may exhibit a degree of mobility in
the synapses of hippocampal neurons, which, to some extent,
is in line with the PTEN localization in growth cones [38].
The role of PI3K/PTEN in dendritic spine formation has been
extensively  studied.  Initial  investigations  reported  that  direct
PI3K  inhibition  reduces  spine  density  and  that  expression  of
constitutively  active  PI3K  increases  the  number  of  filopodia
[24]. Other activators of the PI3K pathway, such as insulin or a
PI3K-activating  transduction  peptide,  promote  dendritic  spine
formation [39,40]. It is also of note that PTEN functions as an
important  mediator  of  spinogenesis  in  mice  by  involving  a
PI3K-mTOR  pathway  [5,9].  Although  DBN  modulates  spine
morphogenesis, and PI3K/PTEN is required for the formation
and remodeling of spines, we were not able to reveal a direct
link between DBN and this signaling pathway (Figure 3). It is
temping to speculate that PTEN could potentially act in a PI3K-
dependent fashion to regulate spine morphogenesis, whilst its
contributions in PI3K-independent responses may be involved
in other neuronal functions. In this context it is of note that loss
of  Pdk1  (Phosphoinositide-dependent  kinase-1),  which
encodes a positive downstream regulator of the PI3K pathway,
appears  to  be  unable  to  rescue  PTEN-mediated  deficits  in
spatial  memory  [8]  and  support  the  idea  that  PTEN  can  act
independent of PI3K signaling in a context dependent manner.
In  summary,  we  identified  a  novel  mechanism  by  which
PTEN responds to synaptic activity through dissociation from a
DBN complex, leading to a de-repression of phosphorylation of
DBN at S647. DBN is phosphorylated at numerous additional
sites.  Finding  out  whether  these  sites  are  phosphorylated
simultaneously  on  the  same  molecule,  function  in  the  same
brain  region,  or  exert  their  functions  in  coordinated  or
antagonizing ways will be a key to understanding this important
cytoskeletal regulator at the CNS synapse.
Materials and Methods
Animal procedures
All animal procedures (breeding/sacrifice) were conducted in
accordance with local ethical guidelines and approved animal
care protocols (London: KCL Ethics Committee and the Home
Office - license 70/6475; Berlin: Institutional Animal Care and
Use  Committee  (IACUC)  and  the  Landesamt  für  Gesundheit
und  Soziales  (LAGeSo)  -  license  T  0347/11;  Heidelberg:
Animal Care and Use Committee and the state government of
Baden-Württemberg - license T56/11).
Immunoprecipitations and tandem mass spectrometry
Immunoprecipitation  and  tandem  mass  spectrometry  were
performed  as  described  previously  [41].  For  co-
immunoprecipitation  experiments,  HEK293  cells  were
transfected with different constructs using Lipofectamine 2000,
lysed in 50 mM Tris pH 7.5; 150 mM NaCl; 1% Triton X-100; 2
µM NaOV and 500 µM NaF and immunoprecipitated with anti-
FLAG®  M2  Affinity  Gel  (Sigma)  to  isolate  the  3xFlag-DBN
complex.  Western  blot  analysis  of  immunoprecipitates  was
performed  using  anti-FLAG  (Sigma),  anti-GFP  (ABCAM)  or
anti-PTEN antibodies (Santa Cruz or Cell Signalling).
Cloning
Full  length  DBN  (accession  number  NM_004395.3)  was
amplified  by  PCR  using  the  primers  5’-
gaattcagccggcgtcagcttcagcgg-3’  and  5’-
ggatccctaatcaccaccctcgaagccctc-3’  and  inserted  in  p3x-Flag-
CMV-7.1 (Sigma). Site directed mutagenesis was performed on
parental peYFP-DBN using QuikChange II XL mutagenesis kit
(Stratagene).  All  mutations  were  validated  by  sequencing.
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been  described  previously  [42].  For  FLIM  experiments  in
hippocampal neurons, DBN and PTEN were cloned into pCAX
vector. DBN shRNA targeted to a rat/mouse specific sequence
gaaccagaaagtgatgtac  was  constructed  into  pSilencer  2.0-U6
(Ambion)  using  the  oligonucleotides  5’-
gatccgaaccagaaagtgatgtacttcaagagagtacatcactttctggttctcttttttgg
aaa-3’  and  5’-
agcttttccaaaaaagagaaccagaaagtgatgtactctcttgaagtacatcactttctg
gttcg-3’
Generation of pS647-DBN antibody
A rabbit polyclonal antiserum was raised against a phospho-
serine  647-encoded  synthetic  DBN  peptide
(CGYFSQS(P)QEEEF; Eurogentec); S647 corresponds to the
sequence of human adult DBN. Antibodies were affinity-purified
by  Sulfolink  column  chromatography  (Thermo  Scientific).
Antibodies were eluted from the phospho-peptide column using
100  mm  glycine,  pH2.5  and  dialyzed  with  PBS.  In  order  to
absorb antibodies reacting with non-phosphorylated peptides,
the eluate was incubated for 1h with the corresponding non-
phosphorylated  peptide.  Affinity  purified  DBN  phospho-
antibodies  were  stored  at  -20  °C.  In  p-peptide  inhbition
experiments, the phospho-serine 647-encoded synthetic DBN
peptide was applied at a concentration of 100 µM.
Western blot analyses
Western  blot  analysis  and  immunocytochemistry  were
performed using anti-FLAG (Sigma), anti-GFP (ABCAM), anti-
DBN-Guinea Pig (Fitzgerald), anti-DBN-mouse M2F6 (Abcam)
anti-PTEN (Santa Cruz), anti-Akt (Cell Signalling Technology),
anti-pS473-Akt  (Cell  Signalling  Technology),  anti  GAPDH
(Abcam), anti-P44/42-MAPK (Cell Signalling Technology), anti-
p514/509-CRMP  (kindly  provided  by  Calum  Sutherland,
Dundee), anti-actin (Millipore) and the generated pS647-DBN
(Eurogentec). All antibodies used for western blotting were at
1/1000 except both anti-GFP and anti-actin used at 1/5000 and
anti-GAPDH  used  at  1/30000.  In  immunohistochemistry
applications, the cells were fixed using 4% paraformaldehyde
and antibodies were used at 1/200. The drebrin antibody used
was anti-DBN (Guinea Pig), unless otherwise stated.
Cell culture, transfection and viral transduction
HEK293 and U87MG cell lines were purchased from ATCC.
All  reagents  were  from  Invitrogen  unless  stated  otherwise.
Primary  rat  hippocampal  or  cortical  neurons  were  prepared
from  E18  Sprague  Dawley  rat  embryos  (Charles  River
Laboratory).  After  hippocampi  isolation,  tissue  pieces  were
dissociated in 0.5 mg/ml trypsin (Worthington) in HBSS for 15
min at 37°C, then washed extensively and gently triturated in
Neurobasal  medium  supplemented  with  1%  Glutamax,  1%
FCS,  2%  B27  and  1%  Penicillin/Streptomycin  using  a  glass
fire-polished Pasteur pipette. Primary mouse hippocampal and
cortical neurons were prepared from E15.5 flox/flox PTEN mice
as  described,  however,  with  a  further  wash  in  10%  horse
serum  before  trituration.  Neurons  were  plated  on  glass
coverslips (Karl Hecht) previously coated with poly-L-lysine and
laminin (both 10µg/ml, Sigma) and maintained in 1% FCS, 2%
B27 supplemented Neurobasal medium. Neurons were plated
at a density of ~300 cells/mm2. All constructs were transfected
using Lipofectamine 2000. DNA and lipofectamine were added
to Optimem at a ratio of 1µg:1µl and incubated for 30 minutes
before transfection. 50% of the medium was removed from the
cultures and replaced with fresh medium. The transfection mix
was added to the culture medium for 30 minutes before being
carefully removed and replaced with a 1:1 ratio of conditioned
to fresh medium. HEK293, U87MG and hippocampal neurons
were  transfected  using  Lipofectamine  2000  and  cortical
neurons  were  transfected  using  Amaxa  Nucleofector  kit
(Lonza).
For viral transduction, a modified lentiviral vector [43,44] was
used,  in  which  a  human  Synapsin-1  promoter  drives  the
expression  of  a  RFP-Cre  transgene.  Lentiviruses  were
produced by co-transfecting HEK293T cells with the lentiviral
vector and two helper vectors, pVSVg and pCMV-delta R8.9
[43]. Viral supernatants were collected 48 hrs after transfection,
and  virus  particles  were  added  to  cultured  floxed  PTEN
neurons  13  days  after  plating  in  ratios  ranging  from
approximately  0.5/1  to  2.5/1,  respectively.  6  days  post-
transduction  neurons  were  harvested  in  RIPA  buffer  with
freshly  added  protease  and  phosphatase  inhibitor  cocktails
(Sigma-Aldrich)  and  lysates  were  prepared  for  Western
blotting.
FRET measurements by Fluorescence Lifetime Imaging
Microscopy (FLIM)
Spatial interaction between PTEN and DBN were measured
in  PC12  cells  transfected  with  different  constructs  using
Lipofectamine  2000.  Following  fixation,  FLIM  experiments  to
measure Förster resonance energy transfer (FRET) and data
analysis  were  performed  as  described  previously  [45].
Dissociated  E18  hippocampal  neurons  were  transfected  at
DIV7 with pCAX-mCherry-DBN and/or pCAX-GFP-PTEN and
imaged at DIV10.
Generation of cell-permeate peptides
A plasmid based on pBR322 was constructed incorporating
bases  coding  for  the  sequence  of  the  D-loop  sequence
(PGPEETSEKVENGSLCDQEIDSICSIERADN)  preceded  by  a
Hisx6  N-terminal  tag  and  the  Antennapedia  sequence
(RQIKIWFQNRRMKWKK).  E.  coli  strain  BL21(DE3)  was
transformed with 10ng of plasmid, transferred to 1 L LB broth
supplemented with Ampicillin (100µg/mL) and grown overnight
at  37°C  to  mid-log  phase  (A600  0.5–0.6).  Peptides  were
induced  with  1  mM  IPTG  for  3  h  and  the  bacteria  were
harvested by centrifugation. Bacterial pellets were treated with
Bugbuster  Reagent  (Novagen,  UK)  according  to
manufacturers’ instructions and the lysate was passed through
a  Ni-NTA  His  Bind  Resin  (Novagen).  Bound  peptide  was
washed and eluted with imidazole according to manufacturers
instructions,  and  dialyzed  overnight.  For  long  term  storage,
peptides were finally dried and stored at -20oC until use.
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electrophysiological recordings
Six  to  8-day-old  male  Wistar  rats  were  used  for  the
preparation  of  organotypic  hippocampal  slice  cultures
according to the interface method [46,47]. Both preparation and
medium  exchanges  were  performed  with  sterile  equipment
(HERAsafe,  Kendro  Laboratory  products).  Organotypic  slices
were randomly prepared on a weekly basis from three different
animals. After decapitation, the hippocampus was isolated and
transversely cut in 400µm-thick-slices with a McIllwain tissue
chopper (Mickle Laboratory Engineering Co.Ltd, Surrey, UK).
Then the slices were transferred in ice-cold dissection medium
(Minimum  Essential  Medium  1.6%  w/v  (Gibco,  Grand  Island,
NY, USA) in sterile distilled water, buffered with Tris base 7-9
(Sigma-Aldrich  Chemie  GbMH,  Steinheim,  Germany)  to  pH
7.35).  Slices  were  rigorously  bubbled  with  a  gas  mixture  of
95% oxygen (O2) and 5% carbon dioxide (CO2) and pair-wise
affixed  on  Millicell®-CM,  0.4µm  porous  membrane  inserts
(Millipore  GmbH,  Schwalbach/Ts,  Germany).  The  bottom  of
each  insert  was  in  contact  with  1ml  of  incubation  medium
(Minimum Essential Medium 1.06% w/v (Gibco, Grand Island,
NY,  USA),  Hanks’  Balanced  Salt  Solution  (Sigma-Aldrich
Chemie  GmBH)  25%  v/v,  L-glutamine  (Gibco)  2mM,  heat-
inactivated  horse  serum  (Gibco)  25%  v/v,  buffered  with
NaHCO3  58‰  w/v  and  Trisbase  7-9  (Sigma-Aldrich  Chemie
GbMH, Steinheim, Germany) to pH 7.35), so that the porous
membrane allowed for exchange of nutrients and the gaseous
phase  for  supplementation  of  oxygen.  The  slices  were
incubated  at  normal  air  with  5%  carbogen  dioxide  (CO2)
(UniEquip  GmbH,  Munich,  Germany)  at  37°C  and  the
incubation medium was fully exchanged three-times-weekly. All
solutions were prepared under the hood and filtered with 0.2
µm pore diameter sterile filters.
For  electrophysiological  recordings,  slice  cultures  were
transferred  to  a  custom-made  interface  recording  chamber
(34°C),  which  was  perfused  with  artificial  cerebrospinal  fluid
(aCSF,  NaCl  129mM,  NaH2PO4  *  H2O  1.25mM,  D-glucose
10mM,  MgSO4  1.8mM,  KCl  3mM,  CaCl2  *  2  H2O  1.6mM,
NaHCO3 21mM) at a flow rate of 1.5ml/min, gassed with 95%
O2 / 5% CO2 at 1lt/min. Local field potentials were recorded
with  silver/silver  chloride  glass  microelectrodes  of  3-8  MΩ
resistance.  Voltage  changes  were  low-pass  filtered  at  3kHz
and  digitized  at  10kHz  using  a  CED  Micro  1401-III®  data
acquisition  unit  and  Spike2®  software  (Cambridge  Electronic
Design  Limited).  Slice  cultures  (8-11  DIV)  were  exposed  to
either 500nM tetrodotoxin (TTX) (BIOTREND Chemikalien) or
5µM gabazine (SR-95531) (Sigma) in the recording chamber;
neuronal network activity was monitored in stratum pyramidale
of the CA3 subfield. After recordings, slice cultures were snap
frozen and stored at -80oC until further processing. For western
blot analyses three slices exhibiting no- or seizure-like activity
were  merged  for  tissue  homogenization.  Data  analysis  was
performed  in  Matlab  (Mathworks).  The  amplitude  (in  mV)  of
seizure-like events was calculated from the difference of the
maximum  to  the  minimum  point,  and  their  frequency  (in  Hz)
from the ratio of occurrences over a time period of 1000s. Data
analysis  was  performed  in  Matlab  (Mathworks,  Natick,  MA,
USA). The amplitude (in mV) of gabazine-induced epileptiform
events was calculated from the difference of the maximum to
the minimum point, and their frequency (in Hz) from the ratio of
occurrences over a time period of 1000s.
Statistical analysis
Student’s t test was used to analyse differences between two
conditions.  Quantifications  of  western  blots  were  analysed
against  a  theoretical  mean  of  1  using  a  one-sample  test.
Variances between three conditions were analysed by two-way
analysis of variance (ANOVA) with Bonferroni post test using
Prism software.
Acknowledgements
We  thank  Phillip  Gordon-Weeks  and  Dan  Worth  for  the
bacterially expressed HIS-DBN protein. We would like to thank
Robert  Hindges  and  Frank  Gertler  for  providing  various
expression  vectors  and  cDNAs.  We  also  thank  Janina
Mukanowa  for  advice  on  high  frequency  stimulation,  Lloyd
Trotman  for  PTENflox/flox  mice,  as  well  as  Christian
Rosenmund and Thorsten Trimbuch for providing Cre-viruses.
Author Contributions
Conceived and designed the experiments: PK IEP MvD NRL
OK BJE. Performed the experiments: PK RH LK IEP MvD TM
JR MP. Analyzed the data: PK IEP MvD TM MP. Contributed
reagents/materials/analysis  tools:  JR  AH  NRL.  Wrote  the
manuscript: PK BJE.
References
1. Song MS, Salmena L, Pandolfi PP (2012) The functions and regulation
of the PTEN tumour suppressor. Nat Rev Mol Cell Biol 13: 283–296.
doi:10.1038/nrm3330. PubMed: 22473468.
2. Backman  SA,  Stambolic  V,  Suzuki  A,  Haight  J,  Elia  A  et  al.  (2001)
Deletion of Pten in mouse brain causes seizures, ataxia and defects in
soma size resembling Lhermitte-Duclos disease. Nat Genet 29: 396–
403. doi:10.1038/ng782. PubMed: 11726926.
3. Butler  MG,  Dasouki  MJ,  Zhou  X-P,  Talebizadeh  Z,  Brown  M  et  al.
(2005)  Subset  of  individuals  with  autism  spectrum  disorders  and
extreme  macrocephaly  associated  with  germline  PTEN  tumour
suppressor gene mutations. J Med Genet 42: 318–321. doi:10.1136/
jmg.2004.024646. PubMed: 15805158.
4. Greer JM, Wynshaw-Boris A (2006) Pten and the brain: sizing up social
interaction.  Neuron  50:  343–345.  doi:10.1016/j.neuron.2006.04.021.
PubMed: 16675386.
5. Kwon C-H, Luikart BW, Powell CM, Zhou J, Matheny SA et al. (2006)
Pten  regulates  neuronal  arborization  and  social  interaction  in  mice.
Neuron  50:  377–388.  doi:10.1016/j.neuron.2006.03.023.  PubMed:
16675393.
6. Endersby R, Baker SJ (2008) PTEN signaling in brain: neuropathology
and  tumorigenesis.  Oncogene  27:  5416–5430.  doi:10.1038/onc.
2008.239. PubMed: 18794877.
7. Fraser  MM,  Bayazitov  IT,  Zakharenko  SS,  Baker  SJ  (2008)
Phosphatase  and  tensin  homolog,  deleted  on  chromosome  10
deficiency in brain causes defects in synaptic structure, transmission
and plasticity, and myelination abnormalities. Neuroscience 151: 476–
488. doi:10.1016/j.neuroscience.2007.10.048. PubMed: 18082964.
8. Sperow  M,  Berry  RB,  Bayazitov  IT,  Zhu  G,  Baker  SJ  et  al.  (2012)
Phosphatase  and  tensin  homologue  (PTEN)  regulates  synaptic
plasticity  independently  of  its  effect  on  neuronal  morphology  and
PTEN Regulates Drebrin Phosphorylation
PLOS ONE | www.plosone.org 11 August 2013 | Volume 8 | Issue 8 | e71957migration.  J  Physiol  Lond  590:  777–792.  doi:10.1113/jphysiol.
2011.220236. PubMed: 22147265.
9. Zhou  J,  Blundell  J,  Ogawa  S,  Kwon  C-H,  Zhang  W  et  al.  (2009)
Pharmacological  inhibition  of  mTORC1  suppresses  anatomical,
cellular, and behavioral abnormalities in neural-specific Pten knock-out
mice.  J  Neurosci  29:  1773–1783.  doi:10.1523/JNEUROSCI.
5685-08.2009. PubMed: 19211884.
10. Jurado S, Benoist M, Lario A, Knafo S, Petrok CN et al. (2010) PTEN is
recruited  to  the  postsynaptic  terminal  for  NMDA  receptor-dependent
long-term  depression.  EMBO  J  29:  2827–2840.  doi:10.1038/emboj.
2010.160. PubMed: 20628354.
11. Planchon SM, Waite KA, Eng C (2008) The nuclear affairs of PTEN. J
Cell Sci 121: 249–253. doi:10.1242/jcs.022459. PubMed: 18216329.
12. Leslie NR, Maccario H, Spinelli L, Davidson L (2009) The significance
of PTEN’s protein phosphatase activity. Adv Enzyme Regul 49: 190–
196. doi:10.1016/j.advenzreg.2008.12.002. PubMed: 19168090.
13. Hayashi  K,  Ishikawa  R,  Ye  LH,  He  XL,  Takata  K  et  al.  (1996)
Modulatory role of drebrin on the cytoskeleton within dendritic spines in
the rat cerebral cortex. J Neurosci 16: 7161–7170. PubMed: 8929425.
14. Ivanov A, Esclapez M, Pellegrino C, Shirao T, Ferhat L (2009) Drebrin
A regulates dendritic spine plasticity and synaptic function in mature
cultured hippocampal neurons. J Cell Sci 122: 524–534. doi:10.1242/
jcs.033464. PubMed: 19174472.
15. Takahashi H, Yamazaki H, Hanamura K, Sekino Y, Shirao T (2009)
Activity of the AMPA receptor regulates drebrin stabilization in dendritic
spine  morphogenesis.  J  Cell  Sci  122:  1211–1219.  doi:10.1242/jcs.
043729. PubMed: 19339553.
16. Takahashi H, Mizui T, Shirao T (2006) Down-regulation of drebrin A
expression  suppresses  synaptic  targeting  of  NMDA  receptors  in
developing hippocampal neurones. J Neurochem 97 Suppl 1: 110–115.
doi:10.1111/j.1471-4159.2005.03536.x. PubMed: 16635259.
17. Shiraishi-Yamaguchi Y, Sato Y, Sakai R, Mizutani A, Knöpfel T et al.
(2009)  Interaction  of  Cupidin/Homer2  with  two  actin  cytoskeletal
regulators, Cdc42 small GTPase and Drebrin, in dendritic spines. BMC
Neurosci 10: 25. doi:10.1186/1471-2202-10-25. PubMed: 19309525.
18. Takahashi  H,  Sekino  Y,  Tanaka  S,  Mizui  T,  Kishi  S  et  al.  (2003)
Drebrin-dependent  actin  clustering  in  dendritic  filopodia  governs
synaptic  targeting  of  postsynaptic  density-95  and  dendritic  spine
morphogenesis. J Neurosci 23: 6586–6595. PubMed: 12878700.
19. Harigaya Y, Shoji M, Shirao T, Hirai S (1996) Disappearance of actin-
binding  protein,  drebrin,  from  hippocampal  synapses  in  Alzheimer’s
disease.  J  Neurosci  Res  43:  87–92.  doi:10.1002/jnr.490430111.
PubMed: 8838578.
20. Lee JO, Yang H, Georgescu MM, Di Cristofano A, Maehama T et al.
(1999) Crystal structure of the PTEN tumor suppressor: implications for
its phosphoinositide phosphatase activity and membrane association.
Cell  99:  323–334.  doi:10.1016/S0092-8674(00)81663-3.  PubMed:
10555148.
21. Trotman LC, Wang X, Alimonti A, Chen Z, Teruya-Feldstein J et al.
(2007)  Ubiquitination  regulates  PTEN  nuclear  import  and  tumor
suppression.  Cell  128:  141–156.  doi:10.1016/j.cell.2006.11.040.
PubMed: 17218261.
22. Joliot A, Prochiantz A (2004) Transduction peptides: from technology to
physiology.  Nat  Cell  Biol  6:  189–196.  doi:10.1038/ncb0304-189.
PubMed: 15039791.
23. Hayashi K, Shirao T (1999) Change in the shape of dendritic spines
caused  by  overexpression  of  drebrin  in  cultured  cortical  neurons.  J
Neurosci 19: 3918–3925. PubMed: 10234022.
24. Kumar V, Zhang M-X, Swank MW, Kunz J, Wu G-Y (2005) Regulation
of  dendritic  morphogenesis  by  Ras-PI3K-Akt-mTOR  and  Ras-MAPK
signaling  pathways.  J  Neurosci  25:  11288–11299.  doi:10.1523/
JNEUROSCI.2284-05.2005. PubMed: 16339024.
25. Ballif  BA,  Villén  J,  Beausoleil  SA,  Schwartz  D,  Gygi  SP  (2004)
Phosphoproteomic  analysis  of  the  developing  mouse  brain.  Mol  Cell
Proteomics  3:  1093–1101.  doi:10.1074/mcp.M400085-MCP200.
PubMed: 15345747.
26. Chew  CS,  Okamoto  CT,  Chen  X,  Thomas  R  (2005)  Drebrin  E2  is
differentially  expressed  and  phosphorylated  in  parietal  cells  in  the
gastric mucosa. Am J Physiol Gastrointest Liver Physiol 289: G320–
G331. doi:10.1152/ajpgi.00002.2005. PubMed: 15790763.
27. Collins  MO,  Yu  L,  Coba  MP,  Husi  H,  Campuzano  I  et  al.  (2005)
Proteomic analysis of in vivo phosphorylated synaptic proteins. J Biol
Chem  280:  5972–5982.  doi:10.1074/jbc.M411220200.  PubMed:
15572359.
28. Rush J, Moritz A, Lee KA, Guo A, Goss VL et al. (2005) Immunoaffinity
profiling of tyrosine phosphorylation in cancer cells. Nat Biotechnol 23:
94–101. doi:10.1038/nbt1046. PubMed: 15592455.
29. Tao  WA,  Wollscheid  B,  O’Brien  R,  Eng  JK,  Li  XJ  et  al.  (2005)
Quantitative phosphoproteome analysis using a dendrimer conjugation
chemistry and tandem mass spectrometry. Nat Methods 2: 591–598.
doi:10.1038/nmeth776. PubMed: 16094384.
30. Vosseller  K,  Hansen  KC,  Chalkley  RJ,  Trinidad  JC,  Wells  L  et  al.
(2005)  Quantitative  analysis  of  both  protein  expression  and  serine  /
threonine  post-translational  modifications  through  stable  isotope
labeling  with  dithiothreitol.  Proteomics  5:  388–398.  doi:10.1002/pmic.
200401066. PubMed: 15648052.
31. Zheng  H,  Hu  P,  Quinn  DF,  Wang  YK  (2005)  Phosphotyrosine
proteomic  study  of  interferon  alpha  signaling  pathway  using  a
combination  of  immunoprecipitation  and  immobilized  metal  affinity
chromatography.  Mol  Cell  Proteomics  4:  721–730.  doi:10.1074/
mcp.M400077-MCP200. PubMed: 15659558.
32. Olsen JV, Blagoev B, Gnad F, Macek B, Kumar C et al. (2006) Global,
in  vivo,  and  site-specific  phosphorylation  dynamics  in  signaling
networks. Cell 127: 635–648. doi:10.1016/j.cell.2006.09.026. PubMed:
17081983.
33. Molina H, Horn DM, Tang N, Mathivanan S, Pandey A (2007) Global
proteomic  profiling  of  phosphopeptides  using  electron  transfer
dissociation tandem mass spectrometry. Proc Natl Acad Sci USA 104:
2199–2204. doi:10.1073/pnas.0611217104. PubMed: 17287340.
34. Dephoure  N,  Zhou  C,  Villén  J,  Beausoleil  SA,  Bakalarski  CE  et  al.
(2008) A quantitative atlas of mitotic phosphorylation. Proc Natl Acad
Sci USA 105: 10762–10767. doi:10.1073/pnas.0805139105. PubMed:
18669648.
35. Sasaki Y, Hayashi K, Shirao T, Ishikawa R, Kohama K (1996) Inhibition
by  drebrin  of  the  actin-bundling  activity  of  brain  fascin,  a  protein
localized  in  filopodia  of  growth  cones.  J  Neurochem  66:  980–988.
PubMed: 8769857.
36. Tada  T,  Sheng  M  (2006)  Molecular  mechanisms  of  dendritic  spine
morphogenesis. Curr Opin Neurobiol 16: 95–101. doi:10.1016/j.conb.
2005.12.001. PubMed: 16361095.
37. Myers MP, Stolarov JP, Eng C, Li J, Wang SI et al. (1997) P-TEN, the
tumor suppressor from human chromosome 10q23, is a dual-specificity
phosphatase.  Proc  Natl  Acad  Sci  USA  94:  9052–9057.  doi:10.1073/
pnas.94.17.9052. PubMed: 9256433.
38. Chadborn NH, Ahmed AI, Holt MR, Prinjha R, Dunn GA et al. (2006)
PTEN couples Sema3A signalling to growth cone collapse. J Cell Sci
119: 951–957. doi:10.1242/jcs.02801. PubMed: 16495486.
39. Cuesto G, Enriquez-Barreto L, Caramés C, Cantarero M, Gasull X et al.
(2011)  Phosphoinositide-3-kinase  activation  controls  synaptogenesis
and spinogenesis in hippocampal neurons. J Neurosci 31: 2721–2733.
doi:10.1523/JNEUROSCI.4477-10.2011. PubMed: 21414895.
40. Lee C-C, Huang C-C, Hsu K-S (2011) Insulin promotes dendritic spine
and  synapse  formation  by  the  PI3K/Akt/mTOR  and  Rac1  signaling
pathways.  Neuropharmacology  61:  867–879.  doi:10.1016/
j.neuropharm.2011.06.003. PubMed: 21683721.
41. Van Diepen MT, Parsons M, Downes CP, Leslie NR, Hindges R et al.
(2009) MyosinV controls PTEN function and neuronal cell size. Nat Cell
Biol 11: 1191–1196. doi:10.1038/ncb1961. PubMed: 19767745.
42. Leslie NR, Gray A, Pass I, Orchiston EA, Downes CP (2000) Analysis
of the cellular functions of PTEN using catalytic domain and C-terminal
mutations:  differential  effects  of  C-terminal  deletion  on  signalling
pathways downstream of phosphoinositide 3-kinase. Biochem J 346 3:
827-833.  Available:  http://www.biochemj.org/bj/346/0827/
bj3460827.htm.  Accessed:  10  June  2013.  doi:
10.1042/0264-6021:3460827. PubMed: 10698713.
43. Lois C, Hong EJ, Pease S, Brown EJ, Baltimore D (2002) Germline
transmission and tissue-specific expression of transgenes delivered by
lentiviral vectors. Science 295: 868–872. doi:10.1126/science.1067081.
PubMed: 11786607.
44. Xue M, Lin YQ, Pan H, Reim K, Deng H et al. (2009) Tilting the balance
between  facilitatory  and  inhibitory  functions  of  mammalian  and
Drosophila  Complexins  orchestrates  synaptic  vesicle  exocytosis.
Neuron  64:  367–380.  doi:10.1016/j.neuron.2009.09.043.  PubMed:
19914185.
45. Parsons  M,  Messent  AJ,  Humphries  JD,  Deakin  NO,  Humphries  MJ
(2008)  Quantification  of  integrin  receptor  agonism  by  fluorescence
lifetime  imaging.  J  Cell  Sci  121:  265–271.  doi:10.1242/jcs.018440.
PubMed: 18216331.
46. Stoppini L, Buchs PA, Muller D (1991) A simple method for organotypic
cultures  of  nervous  tissue.  J  Neurosci  Methods  37:  173–182.  doi:
10.1016/0165-0270(91)90128-M. PubMed: 1715499.
47. Kovács  R,  Rabanus  A,  Otáhal  J,  Patzak  A,  Kardos  J  et  al.  (2009)
Endogenous  nitric  oxide  is  a  key  promoting  factor  for  initiation  of
seizure-like  events  in  hippocampal  and  entorhinal  cortex  slices.  J
Neurosci  29:  8565–8577.  doi:10.1523/JNEUROSCI.5698-08.2009.
PubMed: 19571147.
PTEN Regulates Drebrin Phosphorylation
PLOS ONE | www.plosone.org 12 August 2013 | Volume 8 | Issue 8 | e71957